Pay in 4 interest-free payments of $29.23 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Description: Tocilizumab (Actemra®) is an immunosuppressive humanized monoclonal antibody drug
BS78191-100
Target Symptom: FLJ34254
Catalogue Numbers: BS77838-50
Immunogen: Recombinant protein corresponding to human Cytokeratin 18
Recombinant Human CD40/TNFRSF5 Protein (His Tag)(Active) - PKSH033723 Secondary Antibody Description: Tocilizumab (Actemra®) is anRecombinant Human CD40 TNFRSF5 Protein (His Tag)(Active) Size: 50g Catalogue Number: PKSH033723 50 Citations, Manuals and MSDS Available upon request. Abbreviation: CD40; TNFRSF5 Target Symptom: Tumor Necrosis Factor Receptor Superfamily member 5; B Cell Surface Antigen CD40; Bp50; CD40L Receptor; CDw40; CD40; TNFRSF5 Research Area: Cardiovascular; immunology; Stem cells Target Species: Human Expression Host: HEK293 Cells Application: ELISA Fusion
US$ 119.60
US$ 25.00
US$ 25.00
US$ 49.95